Home
Projects
Posts
Publications
Our Team
Job Opportunities
Contact
Yuval Kluger
Latest
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.
Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.
Cite
×